Dr Horton Stock Beta
| HO2 Stock | EUR 134.10 2.98 2.27% |
DR Horton fundamentals help investors to digest information that contributes to DR Horton's financial success or failures. It also enables traders to predict the movement of HO2 Stock. The fundamental analysis module provides a way to measure DR Horton's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DR Horton stock.
HO2 |
DR Horton Company Beta Analysis
DR Horton's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current DR Horton Beta | 1.53 |
Most of DR Horton's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Horton is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, DR Horton has a Beta of 1.5296. This is 82.1% higher than that of the Consumer Cyclical sector and 49.96% higher than that of the Residential Construction industry. The beta for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DR Horton will likely underperform.
HO2 Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 31.96 B | |||
| Shares Outstanding | 343.39 M | |||
| Shares Owned By Insiders | 14.53 % | |||
| Shares Owned By Institutions | 88.85 % | |||
| Price To Earning | 9.45 X | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 33.48 B | |||
| Gross Profit | 10.07 B | |||
| EBITDA | 7.65 B | |||
| Net Income | 5.86 B | |||
| Cash And Equivalents | 637.7 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 37.90 % | |||
| Current Ratio | 7.18 X | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 15.11 X | |||
| Price To Earnings To Growth | 1.80 X | |||
| Target Price | 111.69 | |||
| Number Of Employees | 13.24 K | |||
| Beta | 1.53 | |||
| Market Capitalization | 30.06 B | |||
| Total Asset | 30.35 B | |||
| Z Score | 3.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.87 % | |||
| Net Asset | 30.35 B | |||
| Last Dividend Paid | 0.93 |
About DR Horton Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Horton's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR Horton using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Horton based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in HO2 Stock
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in HO2 Stock please use our How to Invest in DR Horton guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.